BEXOSOM 4G

A 100% natural biological product from Biocell Ultravital developed to help optimize extracellular and intracellular communication. Its formula is composed of extracellular nano vesicles (Exosomes) from mesenchymal tissue, cellular extracts, enzymes and peptides, a formula that improves intracellular communication, favorably intervening in the behavior of mitosis and its functions, helping to nourish the defective cells of a healthy biological material to contribute to the reprogramming of possible cell defects that are the cause of multiple diseases while improving the reduction of symptoms and a moderate recovery depending on the initial condition of each patient. Intended (mainly) for autoimmune disorders and/or diseases associated with tissue damage.

Conclusion

Bexosom 4G is a safe treatment, which aids in cell-to-cell communication and to optimize much of the cell cycle. Age, genetic disorders, chronic diseases and environmental factors interfere with the way our cells communicate and disrupt the natural process from correct to defective. Due to these influencing factors, your body becomes less efficient in producing healthy cells. Bexosom 4G is a product with natural components that serve to help your body heal cell growth so that it can reprogram cells and restore their natural healing capabilities.

Bexosom
Description:

Bexosom 4G a product that exerts a function in cell-to-cell transit in the human body with pleiotropic functions. Its formula contains placental extracts, peptides, catalytic enzymes and extracellular vesicles that transport nucleic acids, proteins, lipids and metabolites, favoring short and long distance intercellular communication in health and disease and affect various aspects of cell biology in a positive way.

COMPOSITION:

• Vial 2 ml contains 500mg/100MV
• Ultra purified extracellular vesicles 100MV.
• 150 mg lipids of mesenchymal origin Ultra centrifuged (non-native ovine origin).
• Endosomal enzymes.
• Placenta extract 350 mg.

INDICATIONS AS COADJUVANT THERAPY.

Since it is a product developed based on extracellular vesicles (EV), it can help with a series of pathologies, in a large percentage of cases health improvements have been experienced by the use and application of Exosomes from mesenchymal tissue.

BEXOSOM 4G IS INDICATED AS A COADJUVANT PRODUCT IN:

• Endocrine diseases and diabetic foot.
• Cardiovascular diseases.
• Acute renal lesions.
• Brain lesions.
• Parkinson's disease.
• Alzheimer's disease.
• Multiple sclerosis.
• Hepatic lesions.
• Cirrhosis of the liver.
• Digestive system diseases.
• Crohn's disease.
• Peptic ulcer disease.
• Chronic pancreatitis.
• Osteoarthritis.
• Musculoskeletal disorders.
• Pulmonary lesions.
• Revitalization of dermal layers.
• Erectile dysfunction.
• Post-stroke condition.
• CNS lesions.
• Lyme disease.
• Improved athletic performance.

It is important to note that treatment with Bexosom 4G helps in the processes of many of these diseases and even helps to cooperate with the symptoms to prevent their further progression, but it is not a product indicated for the cure of the diseases mentioned above.

The effectiveness of Bexosom 4G therapy depends on multiple factors: duration of the disease, age of the patient, existence of chronic conditions, hereditary predisposition, lifestyle, etc.

MECHANISM OF ACTION.

Its extracellular activity does not comply with the conventional mechanisms of action of allopathic pharmaceuticals, since it is a product with cellular compounds of biological origin, Bexosom 4G comprises three mechanisms to positively affect the intracellular function of the receptor cells through endocytosis, phagocytosis and pinocytosis, promoting in the cells positive stimuli in intracellular exchanges mainly, maximizing nutrition to promote autophagy in defective cells, the other components in its formula participate in a notorious and crucial way in intercellular communication, which has meant a change in the concept of the functions and role played by vesicles and their components in the restoration of damaged tissues and the inflammatory and immunological response, to promote the improvement of some pathologies reducing the symptoms and the possibility in many cases that the disease progresses.

ADMINISTRATION:

Deep intramuscular route, it is recommended to apply slowly in the gluteal region.

DOSAGE / PROTOCOL

FREQUENCY AND RECOMMENDED DOSAGE.

Depending on the age and condition of the patient, the protocol may vary at the discretion of the treating physician.

As an adjuvant treatment for symptomatic patients who already suffer from any of the diseases indicated here, or with a marked family genetic inheritance to contract diseases of the indications mentioned.

1) For people with minor symptoms or at the onset of the disease or with marked genetic inheritance to degenerative diseases, it is recommended to apply 1 dose of 2 ml and repeat the application in 4 weeks and reinforce with the same number of doses every 6 months.

It is recommended to include daily 2 tablets of Cellorgane 4G orally corresponding to the organ or system(s) involved for 2 months at the discretion of the treating physician.

2) For people suffering from the disease with symptoms for more than 3 years, it is recommended to apply 1 dose of 2 ml and repeat the same dose after 3 weeks, reinforce with the same number of doses every 4 months for 1 year and evaluate results.

It is recommended to include daily 2 tablets of Cellorgane 4G orally corresponding to the organ or system(s) involved for 4 months or at the discretion of the treating physician.

NOTE; It is recommended not to interrupt the recommended doses, its therapeutic effect is of continuous action, its efficacy will depend on the continuity of the treatment.

Side effects:

Due to its peptide and opoterapic content in its formula, it may in some cases cause slight headache, which disappears in a few minutes, nausea is very occasional and disappears in a few hours.

Contraindication:

It can be safely combined with other drugs.

In the recommended doses no adverse reactions have been observed in any case.

Those who have diabetes should be first controlled.

Presentation and packaging:

Contains 2 vials of 2 ml and 2 sterile adpater vial devices with cap and safety seal to preserve the quality of each of its different formulas and presentations.

Storage:

Keep in a cool, dry place at room temperature between 5°C and 25°C. Do not use after the expiration date, or when the vial has a broken safety cap, or when the outer package is open or tampered with.

Finished product control:

Two (2) independent laboratories carry out various mycotic tests and controls, biological analysis, type 5 bacteriological analysis, multicenter immuno-cellular tests, anti-brucellosis, virological controls, multiple anti-prion tests, Bacteriosis, Cyclospores, Mycobacteria, Salmonellosis in accordance with the subject of biology for therapeutic purposes for human consumption according to EC regulations in force.

How Does it Work?

Watch Video

How the Formulas are Developed?

All our products have been formulated to optimize cell function because if we have healthy cells, we will be healthier every day, and they are based on our 4 pillars of cellular longevity. They work together as a whole to promote energy production and cell growth.

We strive to achieve perfection for each of our therapeutic categories, since they are formulated by carefully selecting each component after confirming its characteristics and clinical trials that positively compromise the efficacy in each formula, this is basically the science on which our products and therapies are based.

Biocell Ultravital  products  are formulated with ingredients that are 100% natural biological substances, with the highest quality standards, containing cellular extracts of animal origin and peptide hydrolysates extracted from plant extracts and glands of young animals in combination with antioxidants, enzymes and vitamins we managed to optimize the formulas and their therapeutic scope.

All raw material sources are carefully selected from organic plants and organs of pigs and sheep less than one year old and undergo a prion and decontaminated pharmaceutical standardization process that meets high biosecurity standards for reach specific concentrations of high purity and are processed under strict controls to guarantee the high quality and purity of their products.

No chemicals, other harmful or unwanted substances are used in the extraction. Modern technology ensures the recovery of assets in a biologically natural way, without changes. This is very important for the safety of each formula. None of the components in Biocell Ultravital formulas are genetically modified. (NON GMO)

Production and Extraction of Bio Peptides 4th Cellular Generation

The chemical synthesis to produce bioactive peptides of the 4th cell generation of Biocell Ultravital are obtained using combined methods of enzymatic hydrolysis through proteolytic enzymes and by fermentation using starter cultures. This combination of both methods gives origin to peptides with a safer biological activity due to the fact that in one all the contaminating traces are eliminated and the other facilitates the absorption through the intestinal tract. An additional advantage of enzymatic hydrolysis is the reduction of allergens. The procedure to obtain, isolate and identify biopeptides with specific biological activity, is obtained with the solution of the gland or organ to extract biopeptides, to which papain, pepsin, trypsin are added, the application of different enzymes pursue the formation of a mixture with different ranges of biological activity and incubated for a certain time to obtain the desired degree of hydrolysis.

After this, the hydrolyzate is fractionated by exclusion chromatography and semi-preparative liquid chromatography in reverse phase, selecting the fraction with the highest activity as a result of the first invitro tests, and finally the sequence of the peptides responsible for generating the activity is identified. The desired therapy is obtained by applying mass spectrometry and / or N-terminal sequencing. However, hydrolysates are complex mixtures and can contain up to hundreds of different molecules, therefore, locating bioactive peptides in these procedures is a biochemical work of constant expertise that results in a difficult task and requires a lot of time and dedication. The fractions usually still contain multiple compounds that require additional cycles of fractionation, concentration and evaluation of bioactivity to be able to identify the molecule responsible for the activity in the formulas of each product according to the therapeutic indication.

Consequently, the enzymatic hydrolysis used offers undoubted advantages, such as the absence of substrate degradation processes since the enzymes are selective for a type of bond,  pH values ​​between 5 to 10 and the temperatures between 40 to 60ºC, thus maintaining or improving the nutritional value of the protein. The specificity of the enzyme affects the size, quantity, and composition of free peptides and amino acids, as well as their amino acid sequence.

Safety in Therapies

Safety control is a very important factor, especially when it comes to high quality health products, which is why at Biocell Ultravital in France, which is the main headquarters where all the research and development of the formulas take place, we have monitoring and follow-up mechanisms for each product, this to prevent any error in the next production, that is why we are continuously implementing software for the detection of technical failures of the human team in charge of production. This translates into maximum safety controls that guarantee the complete quality of the production, eliminating 100% possible adverse reactions due to the indication of some of our products that does not correspond to a contraindication already described.

This discipline has become responsible for quality control in the formulation and manufacturing phases thanks to the detection, evaluation, knowledge and analysis for the prevention of adverse reactions and other possible problems related to the products, covering a wide spectrum of continuous analysis so that they do not cause any harm to the patient.  We actively participate in decision-making when manufacturing to prevent possible complications in any of the production stages. Thanks to the standardization and development of specific protocols established for each production and subjected to continuous analysis adhering to very specific guidelines we are able to prevent these unwanted complications. We are mandated by compliance with the European Pharmacopoeia in Europe and adhere to current FDA regulations when manufacturing the different products corresponding to Biocell Ultravital Cellular Renovation Therapies.

Research and Development

When Biocell Ultravital incorporates products with new formulas and they reach the market, at least an average of 5 to 7 years have elapsed, consumed in the different phases of research and development. This journey requires a scientific and economic effort, for this reason we say that out of every 300 new formulas that are beginning to be investigated, only 20 end up becoming treatments available to patients either as an adjunct or preventive of cellular function and the immune system.

Working in the context of formulas based on opotherapeutic extracts or cells of xenogeneic origin, they aim to support the expansion of products for basically strengthening the immune system.

Cellular Renovation Therapy may contribute as reinforcement to the primary treatment to treat the various human diseases that are associated with failures of the immune system. In order to achieve this purpose the continuous efforts of a scientific committee structured by various institutions in the field biology headed by Prof. Dr. Ben L Pfizer is needed. These contributions guide new formulations that improve the components has been allocated to four fundamental guidelines with specific objectives corresponding to the 4th generation cellular products by Biocell Ultravital: Protection, Repair, Revitalization and Regeneration properties. These therapeutic lines are developed with a common research and development strategic plan for each product category.

Manufacturing Plants and Procedures

In Europe, research, production and development is carried out at Biocell Ultravital, France, and we share part of the manufacturing in two other associated plants, mainly for the production of some raw materials, between Germany and the Netherlands.

We also manufacture our products in the USA, BIOCELL ULTRAVITAL USA Laboratories, where we have a modern production factory especially for manufacturing formulas and products for oral presentation.

Since our products formulas require components be extracted from a biological source, in all manufacturing plants we have ensured that they are manufactured in production rooms that have state-of-the-art equipment controlled by software that manages the procedures monitoring each phase of the process. Development with the latest air conditioning, quality and safety systems, to ensure that the final product does not lose its therapeutic potency, for this reason the active ingredients of each formula and the preparation in the initial phase are conditioned in isolated clean rooms and by specialized professionals trained to measure and control the production process from the moment this first manufacturing phase begins and continuing these quality controls through each phase of production until the final product is approved.

Each manufacturing plant, although with different facilities, produces with the same manufacturing procedures, efficiently following the highest quality standards that comply with all the regulations established by the European Pharmacopoeia and the FDA.

Products that Improve Cellular Renovation

Currently there is a growing interest in cell therapy extracted from the patient’s own stem cells, unlike our products, Cellular renovation therapies (CRT) provide sustained results without complications and represent a great economic saving in comparison. The products in the Biocell Ultravital line of Cell Renewal Therapies are divided into 5 main groups that include: Regeneration, Revitalization, Detoxification, De-inflammatory and Hormonal.

 CRT have worked with great success in recent years as a preventive treatment, without discarding its effective action as a primary therapeutic. The treatment benefits are notorious for their adjuvant action in allopathic medicine. CRT, through their formulas, exclusively allow us to transform diseased or aging organs into healthy organs with a highly functional capacity.  Their components activate a series of stimuli that cells need for a normal cycle of continuous renewal, and they can be incorporated into the body through injections or orally. These various components are assimilated by the body through endocytosis and a good part is introduced into the cells. This is produced by the emission of pseudopods until they completely encompass it to form a vacuole, which then fuses with the lysosomes to degrade the phagocytosed substance, which is known by the name of phagosome. This method is characterized by being the mode of nutrition used by cells through ingestion of foreign matter. In addition, it is one of the greater means of transport that they use to defend themselves against some cells of multicellular organisms.

From this mechanism and many other stimulating biochemical changes, nutrition begins for an effective CELLULAR RENOVATION. CRT brings a fresh genetic information contained in DNA and RNA, stimulating secretion inducing old or sick cells and reprogramming to operate properly, providing the recipient bodies, a large number of biochemical and enzyme substrates containing information needed to revitalize an organ, or a gland. CRT contains various compounds that are primarily responsible for properly nourishing cells, but, moreover, each of the formulas in a CRT contains cells and embryonal tissues that increase positive changes in cell cycle complementing in part dysfunctional lapses. This is how the different components are first incorporated as essential nutrients and as well, how the embryonic tissues reach the organ  with low vitality and that need to be dynamized. This process is called CELLULAR RENOVATION and its benefits are perceived after several weeks, as it passes slowly from the cell to the tissue, from the tissue to the organ and from the organ to the system. Some specialists feel that the most important result of using CRT is the revitalization of the body’s immune defense mechanisms. When damage occurs to the cells that make up the different tissues and organs involved in the immune system, either through aging or environmental poisoning, the body becomes defenseless from both external invasion and internal degeneration. The damage caused to the organs of the immune system can be reversed by stimulating the body’s defense mechanisms to boost the health of the weakened organ.

Security System to Prevent Falsification

Biocell Ultravital has developed for the 4th generation a sophisticated security system for its products to prevent the repetition of copies and / or counterfeiting of our products. Moving forward, we will invest a great technological effort in each package to ensure that you will have an original product in your hand.

This security system is applied to new packaging that have a QR Scan code applied to a double security system, a first physical stage in the packaging that will reveal through a security tab if the product has been violated and a second with an implantation of sophisticated software that will allow you to check if the product you purchased is original through our website, or by downloading the new BIOCELL APP for Android and IOS for free.

The falsification of ethical and health products is a problem that is becoming increasingly important, and all the different therapeutic areas may be affected.

These counterfeits seek to pass for authentic products, copying the packaging material, the commercial image, the logo, the information brochures, as well as the shape and colors of the original product.

In addition, they use the same lot number, expiration date and other identifying elements of the authentic product. However, they are manufactured and placed on the market without the authorization of any health authority. These original and generic medicines, as well as vitamins are also falsified and even more so those products that enjoy prestige are the most vulnerable and these falsifications may contain active ingredients in incorrect doses or lower doses than those authorized, or the absence of active ingredients and even include some toxic elements. Many may even be manufactured under dangerous conditions that are not controlled. Thus, they can pose a significant risk to health and are sometimes especially difficult to identify.

In short, they look identical to the original product, but contain “uncontrolled” components that are life threatening.

he trade in counterfeit medicines is controlled by international criminal networks, and no region is exempt. Those countries with less controlled drug distribution systems are more vulnerable to this type of practice; However, the most developed countries are not spared from this evil, especially when patients purchase drugs on the internet or unauthorized websites. Unfortunately, in the past we have been victims of these unethical organizations and have had to report these facts to the authorities since many people especially in Asian countries, as well as Mexico and others in Central and South America are victims of misleading offers of therapies, even by unethical doctors who offer the products at prices lower than the real cost. However, in the end they spend more money due to the need to seek immediate clinical help as demonstrated on several occasions reported by us through our attorneys around the world from patients who were treated clinically for administering fake products.